Stability of monoHER in an aqueous formulation for i.v. administration

M.A. Abou el Hassan, D.J. Touw, A.J. Wilhelm, A. Bast, W.J.F. van der Vijgh

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)


MonoHER is a semisynthetic flavonoid used in modulating the cardiotoxic effect of doxorubicin but not its antitumor activity. The oral bioavailability of monoHER is
Original languageEnglish
Pages (from-to)51-56
Number of pages6
JournalInternational Journal of Pharmaceutics
Issue number211
Publication statusPublished - 1 Jan 2000

Cite this